Birks, J (2006). Cholinesterase inhibitors for Alzheimer’s disease. The Cochrane Database of Systematic Reviews 1, CD005593.
Chan, KY, Wang, W, Wu, JJ, Liu, L, Theodoratou, E, Car, J, Middleton, L, Russ, TC, Deary, IJ, Campbell, H, Wang, W, Rudan, I, Global Health Epidemiology Reference Group (GHERG) (2013). Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet (London, England) 381, 2016–2023.
Cooper, C, Livingston, G (2014). Mental health/psychiatric issues in elder abuse and neglect. Clinics in Geriatric Medicine 30, 839–850.
Cooper, C, Selwood, A, Blanchard, M, Walker, Z, Blizard, R, Livingston, G (2010). The determinants of family carers’ abusive behaviour to people with dementia: results of the CARD study. Journal of Affective Disorders 121, 136–142.
Cooper, C, Selwood, A, Livingston, G (2008). The prevalence of elder abuse and neglect: a systematic review. Age and Ageing 37, 151–160.
Daviglus, ML, Bell, CC, Berrettini, W (2010). NIH state-of-the-science conference statement: preventing Alzheimer’s disease and cognitive decline. NIH Consensus and State-Of-The-Science Statements 27, 1–30.
Gallagher, D, Ni Mhaolain, A, Crosby, L, Ryan, D, Lacey, L, Coen, RF, Walsh, C, Coakley, D, Walsh, JB, Cunningham, C, Lawlor, BA (2011). Determinants of the desire to institutionalize in Alzheimer’s caregivers. American Journal of Alzheimer’s Disease and Other Dementias 26, 205–211.
Gitlin, LN, Belle, SH, Burgio, LD, Czaja, SJ, Mahoney, D, Gallagher-Thompson, D, Burns, R, Hauck, WW, Zhang, S, Schulz, R, Ory, MG, REACH Investigators (2003). Effect of multicomponent interventions on caregiver burden and depression: the REACH multisite initiative at 6-month follow-up. Psychology and Aging 18, 361–374.
Livingston, G, Barber, J, Rapaport, P, Knapp, M, Griffin, M, King, D, Livingston, D, Mummery, C, Walker, Z, Hoe, J, Sampson, EL, Cooper, C (2013). Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial. BMJ (Clinical research ed.)
Livingston, G, Sommerlad, A, Orgeta, V, Costafreda, SG, Huntley, J, Ames, D, Ballard, C, Banerjee, S, Burns, A, Cohen-Mansfield, J, Cooper, C, Fox, N, Gitlin, LN, Howard, R, Kales, HC, Larson, EB, Ritchie, K, Rockwood, K, Sampson, EL, Samus, Q, Schneider, LS, Selbaek, G, Teri, L, Mukadam, N (2017). Dementia prevention, intervention, and care. Lancet (London, England) 390, 2673–2734.
Lyketsos, CG, Sheppard, JM, Steinberg, M, Tschanz, JA, Norton, MC, Steffens, DC, Breitner, JC (2001). Neuropsychiatric disturbance in Alzheimer’s disease clusters into three groups: the Cache County study. International Journal of Geriatric Psychiatry 16, 1043–1053.
Mahoney, R, Regan, C, Katona, C, Livingston, G (2005). Anxiety and depression in family caregivers of people with Alzheimer disease: the LASER-AD study. The American Journal of Geriatric Psychiatry 13, 795–801.
McKeith, I, Del Ser, T, Spano, P, Emre, M, Wesnes, K, Anand, R, Cicin-Sain, A, Ferrara, R, Spiegel, R (2000). Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet (London, England) 356, 2031–2036.
National Institute of Health and Care Excellence (2015). Dementia, disability and frailty in later life—mid-life approaches to delay or prevent onset. NICE: London.
Okamura, H, Ishii, S, Ishii, T, Eboshida, A (2013). Prevalence of dementia in Japan: a systematic review. Dementia and Geriatric Cognitive Disorders 36, 111–118.
Prince, M, Wimo, A, Guerchet, M, Ali, GC, Wu, YT, Prina, M (2015). World Alzheimer report 2015—the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International: London.
Savva, GM, Zaccai, J, Matthews, FE, Davidson, JE, McKeith, I, Brayne, C, Medical Research Council Cognitive Function and Ageing Study (2009). Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. The British Journal of Psychiatry 194, 212–219.
World Health Organisation (2017). Draft global action plan on the public health response to dementia. Report by the Director-General, WHO, 3 April, Geneva.